Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate
(128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- Amit K Naskar
- Jaswinder Sharma
- Logan Kearney
- Michael Toomey
- Mike Zach
- Nihal Kanbargi
- Andrew F May
- Arit Das
- Ben Garrison
- Benjamin L Doughty
- Brad Johnson
- Bruce Moyer
- Charlie Cook
- Christopher Bowland
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Edgar Lara-Curzio
- Felix L Paulauskas
- Frederic Vautard
- Holly Humphrey
- Hsin Wang
- James Klett
- Jeffrey Einkauf
- Jennifer M Pyles
- John Lindahl
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Nedim Cinbiz
- Padhraic L Mulligan
- Robert E Norris Jr
- Sandra Davern
- Santanu Roy
- Sumit Gupta
- Tony Beard
- Uvinduni Premadasa
- Vera Bocharova

The technologies described herein provides for the High Temperature Carbonization (HTC) in the manufacturing of carbon fibers (CF). The conventional method for HTC is based in thermal radiation and this technology uses in a liquid medium.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

The widespread use of inexpensive salt hydrate-based phase change materials, or PCMs, has been prevented by a key technical challenge: phase separation, also known as incongruency, which results in the significant degradation of the materials' ability to store thermal energy o

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence